Replimune (REPL) Other Working Capital Changes (2017 - 2026)
Replimune (REPL) posted Other Working Capital Changes of -$234000.0 for Q1 2026, down 25.81% sequentially from -$186000.0 in Q4 2025, and down 25.13% YoY from -$312557.1 in Q1 2025.
Analysis
Replimune (REPL) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Replimune has reported Other Working Capital Changes for 7 years, with the latest figure at -$234000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 25.13% year-over-year to -$234000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$818000.0 (down 13.61% YoY) and the FY2026 annual result came in at -$818000.0, down 13.61% from the prior year.
- Other Working Capital Changes eased to -$234000.0 in Q1 2026 per REPL's latest filing, from -$186000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.2 million in Q3 2024 and troughed at -$1.8 million in Q2 2024.
- A 5-year average of $188352.9 and a median of $140000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 555.22% in 2023, then slumped 3016.67% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$134000.0 in 2022, then jumped by 555.22% to $610000.0 in 2023, then tumbled by 187.38% to -$533000.0 in 2024, then soared by 65.1% to -$186000.0 in 2025, then retreated by 25.81% to -$234000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$234000.0, -$186000.0, and -$82000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Replimune | 1.46 Bn | 1.46 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.13 Mn |
| Jun 30, 2026 | -3.13 Mn |
| Mar 31, 2026 | -213,000.00 |
| Mar 31, 2026 | -213,000.00 |
| Dec 31, 2025 | -207,000.00 |
| Dec 31, 2025 | -207,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -316,000.00 |
| Jun 30, 2025 | -316,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Dec 31, 2024 | -940,000.00 |
| Dec 31, 2024 | -940,000.00 |
| Sep 30, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Mar 31, 2024 | -433,000.00 |
| Mar 31, 2024 | -433,000.00 |